Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Weidemann

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
European Heart Journal|February 25, 2005
The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the diseaseFrank Weidemann, Frank Breunig, Meinrad Beer, et al.
Circulation|March 2, 2012
The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptomsFrank Weidemann, Christian Rummey, Bart Bijnens, et al.
Journal of Cardiac Failure|February 7, 2013
Noncompaction cardiomyopathy is associated with mechanical dyssynchrony: a potential underlying mechanism for favorable response to cardiac resynchronization therapyDiego Penela, Bart Bijnens, Ada Doltra, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 15, 2009
[Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge]Frank Weidemann, Claudia Sommer, Thomas Duning, et al.
JACC. Cardiovascular Imaging|June 18, 2011
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessmentMarkus Niemann, Sebastian Herrmann, Kai Hu, et al.
Heart (British Cardiac Society)|October 23, 2010
The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapyMarkus Niemann, Frank Breunig, Meinrad Beer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 27, 2016
Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip)Julia Wallenborn, Stefan Störk, Sebastian Herrmann, et al.
International Journal of Cardiology|December 17, 2010
Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery diseaseChristian Wolf, Johan M Lorenzen, Sylvia Stein, et al.
Ultrasound in Medicine & Biology|November 19, 2010
Prominent papillary muscles in Fabry disease: a diagnostic marker?Markus Niemann, Dan Liu, Kai Hu, et al.
The American Journal of Cardiology|July 11, 2002
Quantification of regional right and left ventricular function by ultrasonic strain rate and strain indexes after surgical repair of tetralogy of FallotFrank Weidemann, Benedicte Eyskens, Luc Mertens, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
European Heart Journal|February 25, 2005
The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the diseaseFrank Weidemann, Frank Breunig, Meinrad Beer, et al.
Circulation|March 2, 2012
The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptomsFrank Weidemann, Christian Rummey, Bart Bijnens, et al.
Journal of Cardiac Failure|February 7, 2013
Noncompaction cardiomyopathy is associated with mechanical dyssynchrony: a potential underlying mechanism for favorable response to cardiac resynchronization therapyDiego Penela, Bart Bijnens, Ada Doltra, et al.
Medizinische Klinik (Munich, Germany : 1983)|January 15, 2009
[Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge]Frank Weidemann, Claudia Sommer, Thomas Duning, et al.
JACC. Cardiovascular Imaging|June 18, 2011
Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessmentMarkus Niemann, Sebastian Herrmann, Kai Hu, et al.
Heart (British Cardiac Society)|October 23, 2010
The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapyMarkus Niemann, Frank Breunig, Meinrad Beer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 27, 2016
Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip)Julia Wallenborn, Stefan Störk, Sebastian Herrmann, et al.
International Journal of Cardiology|December 17, 2010
Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery diseaseChristian Wolf, Johan M Lorenzen, Sylvia Stein, et al.
Ultrasound in Medicine & Biology|November 19, 2010
Prominent papillary muscles in Fabry disease: a diagnostic marker?Markus Niemann, Dan Liu, Kai Hu, et al.
The American Journal of Cardiology|July 11, 2002
Quantification of regional right and left ventricular function by ultrasonic strain rate and strain indexes after surgical repair of tetralogy of FallotFrank Weidemann, Benedicte Eyskens, Luc Mertens, et al.
Pageof 16